# Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

> **NCT00086177** · PHASE3 · COMPLETED · sponsor: **Juniper Pharmaceuticals, Inc.** · enrollment: 636 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** 8% progesterone vaginal gel
- **DRUG:** Placebo Vaginal Gel

## Key facts

- **NCT ID:** NCT00086177
- **Lead sponsor:** Juniper Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-01
- **Final completion:** 2009-03
- **Target enrollment:** 636 (ACTUAL)
- **Last updated:** 2010-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086177, "Vaginal Progesterone to Reduce the Risk of Another Preterm Birth". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00086177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*